SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-024959
Filing Date
2021-12-13
Accepted
2021-12-13 17:26:45
Documents
13
Period of Report
2021-12-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cdxc-20211213.htm   iXBRL 8-K 33099
5 cdxc-20211213_g1.jpg GRAPHIC 26428
  Complete submission text file 0001628280-21-024959.txt   238896

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdxc-20211213.xsd EX-101.SCH 1893
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdxc-20211213_lab.xml EX-101.LAB 23892
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdxc-20211213_pre.xml EX-101.PRE 12517
6 EXTRACTED XBRL INSTANCE DOCUMENT cdxc-20211213_htm.xml XML 10520
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

IRS No.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 211488984
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences